Rocket


Overview
Financials
News + Filings
IR Vault
Key Docs
Charts
Transactions
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other

Tags
Inv. presentation
Quarterly results
CC transcript
Employment agrmnt
Credit agrmnt [a]

Allied World Assurance Co Holdings, GmbH (AWH) Create: Alert

All | News | Filings
Date FiledTypeDescription
01/12/2022 4 WATSA V PREM ET AL (10% Owner) has filed a Form 4 on Crescent Capital BDC, Inc.
Txns: Sold 32,548 shares @ $18.08, valued at $588.5k
Sold 52,675 shares @ $18.18, valued at $957.6k
01/10/2022 4 WATSA V PREM ET AL (10% Owner) has filed a Form 4 on Crescent Capital BDC, Inc.
Txns: Sold 13,659 shares @ $18.01, valued at $246k
Sold 40,914 shares @ $18.03, valued at $737.7k
Sold 20,238 shares @ $18.02, valued at $364.7k
01/05/2022 4 WATSA V PREM ET AL (10% Owner) has filed a Form 4 on Crescent Capital BDC, Inc.
Txns: Sold 6,471 shares @ $18, valued at $116.5k
Sold 19,795 shares @ $18, valued at $356.3k
Sold 92,020 shares @ $18.01, valued at $1.7M
12/29/2021 4 WATSA V PREM ET AL (10% Owner) has filed a Form 4 on Crescent Capital BDC, Inc.
Txns: Sold 71,187 shares @ $18.01, valued at $1.3M
Sold 102,476 shares @ $18.06, valued at $1.9M
Sold 103,285 shares @ $18.05, valued at $1.9M
12/23/2021 4 WATSA V PREM ET AL (10% Owner) has filed a Form 4 on Crescent Capital BDC, Inc.
Txns: Sold 63,063 shares @ $18.01, valued at $1.1M
Sold 30,303 shares @ $18.13, valued at $549.4k
12/21/2021 4 WATSA V PREM ET AL (10% Owner) has filed a Form 4 on Crescent Capital BDC, Inc.
Txns: Sold 6,770 shares @ $18.25, valued at $123.6k
Sold 28,156 shares @ $18, valued at $506.8k
Sold 52,007 shares @ $18.07, valued at $939.8k
03/25/2021 GN Aspira Women's Health Reports Fourth Quarter and Full Year 2020 Financial Results
02/17/2021 GN Aspira Women's Health Recognizes the Importance of Bridging the Gap in Ovarian Cancer Risk Assessment Disparities During Black History Month
02/12/2021 GN Aspira Women's Health, Inc. to Participate in BTIG's Virtual MedTech, Digital Health, Life Science and Diagnostic Tools Conference
02/10/2021 GN Aspira Women's Health, Inc. to add NCCN Management Recommendations to its Proprietary Aspira GenetiX™ Clinical Report
02/04/2021 5 Form 5 - Annual statement of changes in beneficial ownership of securities:
02/04/2021 GN Aspira Women's Health Inc. Announces Pricing of $45 Million Public Offering of Common Stock
01/04/2021 GN Aspira Women's Health, Inc. to Participate in Virtual Investor Events
11/19/2020 GN Aspira Women's Health, Inc. Announces a Collaborative Agreement with Baylor Genetics for the Co-Development of an Ovarian Cancer Early-Detection Test
11/10/2020 GN Aspira Women's Health, Inc. Strengthens Executive Leadership with New Appointments
11/09/2020 GN Aspira Women's Health Strengthens Board of Directors with the Addition of Dr. Sandra E. Brooks
11/05/2020 GN Aspira Women's Health, Inc. to Present at the Canaccord Genuity Virtual MedTech & Diagnostics Forum
11/04/2020 GN Aspira Women's Health, Inc. to Report Third Quarter 2020 Financial Results on November 12th
10/09/2020 GN Aspira Women's Health, Inc. to Present at MicroCap Rodeo Best Ideas Bowl October 13-16
09/15/2020 GN Aspira Women's Health, Inc. to Host Key Opinion Leader Call on Ovarian Cancer Diagnostics, Innovation Pipeline, and Rebranding Initiatives
09/08/2020 GN Aspira Women's Health, Inc. to Present at Cantor Virtual Healthcare Conference
08/14/2020 GN UPDATE – Aspira Women's Health Reports Second Quarter 2020 Financial Results
07/31/2020 GN Aspira Women's Health, Inc. to Report Second Quarter 2020 Financial Results on August 13th
07/01/2020 GN Aspira Women's Health Inc. Announces Equity Financing of Approximately $11 Million
11/27/2019 SC 13G/A Allied World Assurance Co Holdings, AG reports a 16.7% stake in Crescent Capital BDC, Inc.
11/27/2019 4 Allied World Assurance Co Holdings, GmbH (10% Owner) has filed a Form 4 on Crescent Capital BDC, Inc.
Txns: Bought 97,777 shares @ $20.006, valued at $2M
Bought 166,714 shares @ $20.011, valued at $3.3M
Bought 104,704 shares @ $20.043, valued at $2.1M
Bought 206,837 shares @ $19.547, valued at $4M
Bought 179,209 shares @ $19.681, valued at $3.5M
Bought 346,404 shares @ $19.792, valued at $6.9M
Bought 223,650 shares @ $19.792, valued at $4.4M
Bought 25,029 shares @ $19.403, valued at $485.6k
02/02/2018 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
08/08/2017 425 Form 425 - Prospectuses and communications, business combinations:
08/07/2017 15-12B Form 15-12B - Securities registration termination [Section 12(b)]:
08/04/2017 8-K Quarterly results
08/03/2017 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
08/03/2017 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
08/03/2017 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
08/03/2017 POSASR Form POSASR - Post-effective Amendment to an automatic shelf registration statement:
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy